259 related articles for article (PubMed ID: 17511653)
1. 13C- and 1H-NMR studies of oxyanion and tetrahedral intermediate stabilization by the serine proteinases: optimizing inhibitor warhead specificity and potency by studying the inhibition of the serine proteinases by peptide-derived chloromethane and glyoxal inhibitors.
Malthouse JP
Biochem Soc Trans; 2007 Jun; 35(Pt 3):566-70. PubMed ID: 17511653
[TBL] [Abstract][Full Text] [Related]
2. 13C NMR study of how the oxyanion pKa values of subtilisin and chymotrypsin tetrahedral adducts are affected by different amino acid residues binding in enzyme subsites S1-S4.
O'Sullivan DB; O'Connell TP; Mahon MM; Koenig A; Milne JJ; Fitzpatrick TB; Malthouse JP
Biochemistry; 1999 May; 38(19):6187-94. PubMed ID: 10320347
[TBL] [Abstract][Full Text] [Related]
3. Oxyanion and tetrahedral intermediate stabilisation by subtilisin: detection of a new tetrahedral adduct.
Howe N; Rogers L; Hewage C; Malthouse JP
Biochim Biophys Acta; 2009 Aug; 1794(8):1251-8. PubMed ID: 19393346
[TBL] [Abstract][Full Text] [Related]
4. Importance of tetrahedral intermediate formation in the catalytic mechanism of the serine proteases chymotrypsin and subtilisin.
Petrillo T; O'Donohoe CA; Howe N; Malthouse JP
Biochemistry; 2012 Aug; 51(31):6164-70. PubMed ID: 22757750
[TBL] [Abstract][Full Text] [Related]
5. Determination of the structure of tetrahedral transition state analogues bound at the active site of chymotrypsin using 18O and 2H isotope shifts in the 13C NMR spectra of glyoxal inhibitors.
Spink E; Hewage C; Malthouse JP
Biochemistry; 2007 Nov; 46(44):12868-74. PubMed ID: 17927215
[TBL] [Abstract][Full Text] [Related]
6. NMR study of the inhibition of pepsin by glyoxal inhibitors: mechanism of tetrahedral intermediate stabilization by the aspartyl proteases.
Cosgrove S; Rogers L; Hewage CM; Malthouse JP
Biochemistry; 2007 Oct; 46(39):11205-15. PubMed ID: 17824620
[TBL] [Abstract][Full Text] [Related]
7. 13C-NMR study of the inhibition of delta-chymotrypsin by a tripeptide-glyoxal inhibitor.
Djurdjevic-Pahl A; Hewage C; Malthouse JP
Biochem J; 2002 Mar; 362(Pt 2):339-47. PubMed ID: 11853541
[TBL] [Abstract][Full Text] [Related]
8. Ionisations within a subtilisin-glyoxal inhibitor complex.
Djurdjevic-Pahl A; Hewage C; Malthouse JP
Biochim Biophys Acta; 2005 May; 1749(1):33-41. PubMed ID: 15848134
[TBL] [Abstract][Full Text] [Related]
9. Oxyanion-mediated inhibition of serine proteases.
Presnell SR; Patil GS; Mura C; Jude KM; Conley JM; Bertrand JA; Kam CM; Powers JC; Williams LD
Biochemistry; 1998 Dec; 37(48):17068-81. PubMed ID: 9836602
[TBL] [Abstract][Full Text] [Related]
10. A study of the stabilization of tetrahedral adducts by trypsin and delta-chymotrypsin.
Finucane MD; Malthouse JP
Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):889-900. PubMed ID: 1417749
[TBL] [Abstract][Full Text] [Related]
11. 15N and 1H NMR spectroscopy of the catalytic histidine in chloromethyl ketone-inhibited complexes of serine proteases.
Tsilikounas E; Rao T; Gutheil WG; Bachovchin WW
Biochemistry; 1996 Feb; 35(7):2437-44. PubMed ID: 8652587
[TBL] [Abstract][Full Text] [Related]
12. Determination of the ionization state of the active-site histidine in a subtilisin-(chloromethane inhibitor) derivative by 13C-NMR.
O'Connell TP; Malthouse JP
Biochem J; 1996 Jul; 317 ( Pt 1)(Pt 1):35-40. PubMed ID: 8694783
[TBL] [Abstract][Full Text] [Related]
13. Hemiacetal stabilization in a chymotrypsin inhibitor complex and the reactivity of the hydroxyl group of the catalytic serine residue of chymotrypsin.
Cleary JA; Doherty W; Evans P; Malthouse JP
Biochim Biophys Acta; 2014 Jun; 1844(6):1119-27. PubMed ID: 24657307
[TBL] [Abstract][Full Text] [Related]
14. Properties of the His57-Asp102 dyad of rat trypsin D189S in the zymogen, activated enzyme, and alpha1-proteinase inhibitor complexed forms.
Kaslik G; Westler WM; Gráf L; Markley JL
Arch Biochem Biophys; 1999 Feb; 362(2):254-64. PubMed ID: 9989934
[TBL] [Abstract][Full Text] [Related]
15. Direct observation by X-ray analysis of the tetrahedral "intermediate" of aspartic proteinases.
Veerapandian B; Cooper JB; Sali A; Blundell TL; Rosati RL; Dominy BW; Damon DB; Hoover DJ
Protein Sci; 1992 Mar; 1(3):322-8. PubMed ID: 1304340
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design of a general class of mechanism-based inhibitors of the serine proteinases employing a novel amino acid-derived heterocyclic scaffold.
Groutas WC; Kuang R; Venkataraman R; Epp JB; Ruan S; Prakash O
Biochemistry; 1997 Apr; 36(16):4739-50. PubMed ID: 9125494
[TBL] [Abstract][Full Text] [Related]
17. The thiolase reaction mechanism: the importance of Asn316 and His348 for stabilizing the enolate intermediate of the Claisen condensation.
Meriläinen G; Poikela V; Kursula P; Wierenga RK
Biochemistry; 2009 Nov; 48(46):11011-25. PubMed ID: 19842716
[TBL] [Abstract][Full Text] [Related]
18. 13C and 1H NMR studies of ionizations and hydrogen bonding in chymotrypsin-glyoxal inhibitor complexes.
Spink E; Cosgrove S; Rogers L; Hewage C; Malthouse JP
J Biol Chem; 2007 Mar; 282(11):7852-61. PubMed ID: 17213185
[TBL] [Abstract][Full Text] [Related]
19. X-ray snapshots of serine protease catalysis reveal a tetrahedral intermediate.
Wilmouth RC; Edman K; Neutze R; Wright PA; Clifton IJ; Schneider TR; Schofield CJ; Hajdu J
Nat Struct Biol; 2001 Aug; 8(8):689-94. PubMed ID: 11473259
[TBL] [Abstract][Full Text] [Related]
20. Details of the acyl-enzyme intermediate and the oxyanion hole in serine protease catalysis.
Whiting AK; Peticolas WL
Biochemistry; 1994 Jan; 33(2):552-61. PubMed ID: 8286385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
